Rallybio RLYB
NASDAQ RLYB
$16.83 +0.23 (+1.39%)
As of: Aug 21, 2026 · 3:59 PM EDT

Rallybio (RLYB) Return on Sales (QoQ) (2024 - 2026)

Rallybio (RLYB) Return on Sales (QoQ) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Rallybio 94.61 Mn 94.61 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 110.00
Mar 31, 2026 -13.00
Dec 31, 2025 -102.00
Sep 30, 2025 120.00
Jun 30, 2025 -3.00
Mar 31, 2025 238.00
Dec 31, 2024 -243.00
Sep 30, 2024 16.00